SynthesisClinical rheumatology2025
A systematic review of botulinum toxin as a treatment for Raynaud's disease secondary to scleroderma.
Calver Pang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it